2025-04-08 18:20:06
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
NATCO Pharma Ltd consolidated Q1FY21 up QoQ to Rs. 122.8 crore
Posted On : 2020-08-12 17:04:27( TIMEZONE : IST )
NATCO PHARMA LTD. has reported financial results for the period ended June 30, 2020.
Financial Results (Q1 FY 2020-21) - QoQ Comparison
The company has reported total income of Rs.582.1 crores during the period ended June 30, 2020 as compared to Rs.477.2 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.122.8 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.94.1 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.6.73 for the period ended June 30, 2020 as compared to Rs.5.16 for the period ended March 31, 2020.
| Financials | Q1 FY2020-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 582.1 crs | ₹ 477.2 crs |  21.98% |
| Net Profit | ₹ 122.8 crs | ₹ 94.1 crs | 30.5% |
| EPS | ₹ 6.73 | ₹ 5.16 | 30.43% |
Financial Results (Q1 FY 2020-21) - YoY Comparison
The company has reported total income of Rs.582.1 crores during the period ended June 30, 2020 as compared to Rs.513.3 crores during the period ended June 30, 2019.
The company has posted net profit / (loss) of Rs.122.8 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.143.2 crores for the period ended June 30, 2019.
The company has reported EPS of Rs.6.73 for the period ended June 30, 2020 as compared to Rs.7.85 for the period ended June 30, 2019.
| Financials | Q1 FY2020-21 | Q1 FY2019-20 | % Change |
| Total Income | ₹ 582.1 crs | ₹ 513.3 crs | 13.4% |
| Net Profit | ₹ 122.8 crs | ₹ 143.2 crs |  -14.25% |
| EPS | ₹ 6.73 | ₹ 7.85 | -14.27% |
Increase in revenue was driven primarily by exports formulations business. During the quarter, the company faced margins pressure on both domestic and international formulations. Inspite of lower margins during the first quarter, the company is confident of its business for remaining part of the financial year based on the order book and earnings outlook. The company expects a growth of over 25% in its earnings for FY2020-21 compared to prior year.
Shares of NATCO PHARMA LTD. was last trading in BSE at Rs.843.95 as compared to the previous close of Rs. 865.85. The total number of shares traded during the day was 107510 in over 6241 trades.
The stock hit an intraday high of Rs. 865.65 and intraday low of 815.2. The net turnover during the day was Rs. 90179578.
